QQ客服 官方微博 反馈留言

浏览/检索结果: 共28条，第1-10条 帮助 限定条件 专题：合肥物质科学研究院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor 期刊论文 THORACIC CANCER, 2022 作者:  Wang, Wenxian;  Wang, Qian;  Xu, Chunwei;  Li, Ziming;  Song, Zhengbo 收藏  |  浏览/下载：32/0  |  提交时间：2022/12/23 checkpoint inhibitor pneumonitis  Chinese experts consensus  immune checkpoint inhibitor-related adverse effects   Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文 THORACIC CANCER, 2022 作者:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo 收藏  |  浏览/下载：36/0  |  提交时间：2022/12/22 fusion  precision medicine  solid tumor  targeted therapy  tyrosine receptor kinase   A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17 作者:  Lu, S.;  Zhang, Y.;  Zhang, G.;  Zhou, J.;  Cang, S. 收藏  |  浏览/下载：23/0  |  提交时间：2022/12/23 third-generation EGFR-TKI  befotertinib  T790M   Sugemalimab vs Placebo after cCRT or sCRT in pts with Unresectable Stage III NSCLC: Final PFS Analysis of a Phase 3 Study 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17 作者:  Wu, Y. -L.;  Zhou, Q.;  Chen, M.;  Pan, Y.;  Jian, O. 收藏  |  浏览/下载：22/0  |  提交时间：2022/12/23 CCRT  sCRT  PD-L1 inhibitor   Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li 收藏  |  浏览/下载：30/0  |  提交时间：2022/12/22 Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements 期刊论文 LIVER CANCER, 2022, 卷号: 11 作者:  Sun, Yongkun;  Zhang, Wen;  Bi, Xinyu;  Yang, Zhengqiang;  Tang, Yu 收藏  |  浏览/下载：34/0  |  提交时间：2022/12/23 Chinese interdisciplinary experts  Hepatocellular carcinoma  Molecular targeted therapy  Consensus   Optical properties of Nd3+ ions doped GdTaO4 for pressure and temperature sensing 期刊论文 JOURNAL OF RARE EARTHS, 2022, 卷号: 40 作者:  Zhou, Pengyu;  Zhang, Qingli;  Peng, Fang;  Sun, Baoquan;  Dou, Xiuming 收藏  |  浏览/下载：16/0  |  提交时间：2022/12/23 Trivalent neodymium ion  Rare-earth tantalate  Near-infrared luminescence  Pressure sensing  Temperature sensing   Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR) 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Jin, Jing;  Tang, Yuan;  Hu, Chen;  Jiang, Li-Ming;  Jiang, Jun 收藏  |  浏览/下载：24/0  |  提交时间：2022/12/23 Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial 期刊论文 ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022 作者:  Liu, Jihong;  Yin, Rutie;  Wu, Lingying;  Zhu, Jianqing;  Lou, Ge 收藏  |  浏览/下载：31/0  |  提交时间：2022/05/05 BRCA mutation  China  olaparib  ovarian cancer  PARP inhibitor   Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis 期刊论文 CLINICAL CANCER RESEARCH, 2022, 卷号: 28 作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng 收藏  |  浏览/下载：29/0  |  提交时间：2022/05/05